Today, Cochrane Review released a systematic review update on using e-cigarettes to quit smoking. The update included findings from 17 new studies which provided further evidence that e-cigarettes are a more effective tool than traditional nicotine replacement therapies (NRTs) for smoking cessation.
The Cochrane Review is a respected standard in the medical community, summarizing and explaining scientific and medical research while also providing commentary and meta-analyses on key scientific issues. Their latest report examines the effectiveness, tolerance, and safety of e-cigarettes in aiding smokers to quit. The review analyzed a total of 78 studies, which included 22,052 participants. Of those studies, 40 were randomized controlled trials.
The main findings and conclusions of the Cochrane Review are as follows:
There is "significant and reliable evidence" indicating that electronic cigarettes containing nicotine can increase the likelihood for smokers to successfully quit smoking long-term compared to traditional nicotine replacement therapies.
For every 100 people attempting to quit smoking, e-cigarettes can help an additional four individuals quit compared to traditional nicotine replacement therapy (NRT) users.
Evidence also suggests that nicotine e-cigarettes may be more beneficial for people trying to quit smoking than behavioral support, but researchers believe that this evidence still needs to be confirmed.
According to researchers, there is no evidence that e-cigarettes pose a "serious harm".
According to the results of the Cochrane Review, electronic cigarettes can play a critical role in transitioning several generations of cigarette smokers to low-risk nicotine products. The likelihood of completely quitting smoking increases by 43% when comparing those who use flavorless or tobacco-flavored electronic cigarette products, not including other flavors.
The original report can be viewed by clicking on the link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub7/full.
Statement:
This article is compiled from information provided by a third party and is intended for industry professionals for educational and informational purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is solely for industry exchange and research purposes.
Due to limitations in our ability to translate accurately, this article may not convey the exact same meaning as the original. Please refer to the original text for the most accurate information.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
All compiled information is owned by the original media and authors. If there is any infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
